Composition for preventing or treating liver fibrosis including sanguisorba officinalis extract as active ingredient
AssigneeKorea Institute of Science and Technology
InventorsChu Won NHO, Myungsuk KIM, Yunseong NAM
Life of this patent
Estimating the term…
Abstract
The present invention relates to a composition for preventing or treating liver fibrosis, which includes a Sanguisorba officinalis extract as an active ingredient, and more particularly, to a composition for preventing or treating liver fibrosis, which includes a Sanguisorba officinalis extract or ziyuglycoside. The Sanguisorba officinalis extract or ziyuglycoside of the present invention inhibits liver fibrosis and the expression of a liver fibrosis-related gene, so it may be effectively used in the composition for preventing or treating liver fibrosis.
Claims10
A pharmaceutical composition for preventing or treating liver fibrosis, which comprises a Sanguisorba officinalis extract or ziyuglycoside as an active ingredient.
A health functional food composition for preventing or treating liver fibrosis, which comprises a Sanguisorba officinalis extract or ziyuglycoside as an active ingredient.
Dependencies are inferred from the claim text.